Identification of CD318 (CDCP1) as novel prognostic marker in AML

Genetic and morphological markers are well-established prognostic factors in acute myeloid leukemia (AML). However, further reliable markers are urgently needed to improve risk stratification in AML. CD318 (CDCP1) is a transmembrane protein which in solid tumors promotes formation of metastasis and...

Descripción completa

Detalles Bibliográficos
Autores principales: Heitmann, Jonas S., Hagelstein, Ilona, Hinterleitner, Clemens, Roerden, Malte, Jung, Gundram, Salih, Helmut R., Märklin, Melanie, Kauer, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060168/
https://www.ncbi.nlm.nih.gov/pubmed/31965270
http://dx.doi.org/10.1007/s00277-020-03907-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060168/
https://www.ncbi.nlm.nih.gov/pubmed/31965270
http://dx.doi.org/10.1007/s00277-020-03907-9

Ejemplares similares